Supplying importers and distributors in 15+ countries with WHO-GMP certified oncology and critical care medicines, backed by full export documentation.
Supplier-declared, pending confirmation
Cytotoxic injections and oral anti-cancer agents sourced from WHO-GMP certified Indian manufacturers, available with COPP and COA documentation.
Hospital-grade antibiotics, vasopressors, sedatives, and supportive-care injectables for ICU and acute-care settings.
Prefilled syringe formulations supporting renal anaemia management and anticoagulation therapy.
Branded antihypertensive and cardiovascular tablets from established Indian manufacturers including Cipla Ltd.
Branded tablets and topical solutions for erectile dysfunction, hair loss, and select acute infections.
All products are sourced exclusively from Indian manufacturers holding WHO-GMP certification, and each shipment can be supported with COPP, Free Sale Certificate, and Certificate of Analysis documentation.
Echoes Life Sciences has established supply relationships across the United Kingdom, United Arab Emirates, Kenya, Nigeria, South Africa, Philippines, Saudi Arabia, Iraq, Australia, and other markets, providing familiarity with destination-country import requirements.
The company provides export documentation including COPP, COA, Free Sale Certificates, and product-wise quotations to support regulatory submissions in the buyer's country.
Orders can be structured as bulk supply, private or contract supply, or long-term arrangements, with product-wise quotations available for individual SKUs or full category requirements.
A single trading relationship with Echoes Life Sciences covers oncology, critical care, nephrology, and super-speciality categories under HS codes 3004.90, 3004.20, and 3004.39, reducing the number of separate supplier relationships a buyer needs to manage.
Echoes Life Sciences is a pharmaceutical trading and export company based in India. It does not manufacture products directly; instead, it sources from WHO-GMP certified Indian manufacturers and supplies to importers, distributors, and wholesalers internationally.
The portfolio covers Oncology, Critical Care, Nephrology, and Super Speciality medicines, classified under HS codes 3004.90, 3004.20, and 3004.39. Products include injectable cytotoxics, antibiotic vials, prefilled syringes, and oral oncology tablets.
Current export markets include the United Kingdom, United States, United Arab Emirates, Kenya, Tanzania, Uganda, Zambia, Ghana, Nigeria, South Africa, Philippines, Saudi Arabia, Oman, Iraq, and Australia. Buyers outside these markets are welcome to inquire.
Echoes Life Sciences can provide WHO-GMP Certificate, Certificate of Pharmaceutical Product (COPP), Free Sale Certificate, and Certificate of Analysis (COA) to support import and regulatory clearance in the destination country. Specific document sets depend on the product and manufacturer; confirm requirements at the time of inquiry.
Yes. Echoes Life Sciences offers bulk supply, private or contract supply, and long-term supply arrangements. Product-wise quotations can be provided for individual SKUs or full category requirements.
Use the inquiry form on this page to submit your product list, target quantities, destination country, and contact details. The team will respond with a product-wise quotation.